Search results
Results From The WOW.Com Content Network
Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court.
EPHMRA do market researches regularly, aiming to investigate on the latest development in the pharmaceutical market research to the public, and to advocate pharmaceutical market research policies to the government. Recently, research topics related to digital health, patient engagement and GDPR compliance have been investigated. [1]
Drug Discovery Today is a monthly peer-reviewed scientific journal that is published by Elsevier.It was established in 1996 and publishes reviews on all aspects of preclinical drug discovery from target identification and validation through hit identification, lead identification and optimisation, to candidate selection.
This is a list of notable medical and scientific journals that publish articles in pharmacology and the pharmaceutical sciences This is a dynamic list and may never be able to satisfy particular standards for completeness.
By Krishna N. Das. NEW DELHI (Reuters) - India will make it mandatory for drugmakers to audit their raw material suppliers at least once a year, according to a government document, tightening ...
It provides daily news and analysis on the biotechnology and pharmaceutical industry including areas such as policy & regulation, business news, research & development, generics, drug delivery, and clinical trials. In 2022, Informa sold its Pharma Intelligence division, including Scrip, to Warburg Pincus. [4] The business was renamed Citeline.
This latest financial support comes on top of the $176 million BARDA gave Moderna last summer. “Avian flu variants have proven to be particularly unpredictable and dangerous to humans in the past.
Regulatory developments, FDA/EMEA news, market legislation, pharma market movements, reviews of current and proposed legislation and regulation, conference details, and write-ups. Barbara Obstoj is the Managing Editor, which in 2009 acquired the archives of The Pharma Marketletter, a publication Barbara owned since 1991 and prior to that edited ...